A month ago we returned to the daily routine. Back to work, to getting up soon, and for the little ones, back to the classroom.

School is an essential part of children’s lives, but it is also one of the environments that bring most insecurity to the parents and family of a child that has seizures.

To ensure the safety of the child and that their learning is not affected, it is essential to talk with their teachers and the director. It is important to find out to what extent they are used to dealing with pupils with epilepsy, in addition to providing contact information and instructions on what to do in case of a seizure and how to administer the medication.

It is advisable to participate in trips and extracurricular activities, as they will help them to integrate

Teachers must be able to recognize the early signs of a seizure in order to react in the fastest and most efficient way.

We must also take into account the particularities of each case. In the case of photogenic epilepsy, between 2% and 5% of the total, it must be ensured that projectors, computers or smartboards do not have blinking, intermittent or high contrast patterns.

As long as the necessary precautions are taken, it is advisable for the child to participate in trips and extracurricular activities, as they will help them to integrate with the group and stay active.

Finally, note that it would be a mistake to keep children suffering from epilepsy in an isolated environment. Those who live with the disease already face more difficulties of social integration, especially in adolescent age, since to avoid risks their participation in activities can be limited. In addition, there is still a deep stigma in our culture with direct consequences on the disease.

We must not forget when we were kids we all liked to play, get wet in puddles and look around, so it is the duty of the whole society to give visibility to epilepsy so that it is normalized and better understood by reducing the social rejection to which it exposes and allowing better quality of life to the young people who suffer from it. You can help giving awareness by sharing this article.

Leave a Reply

Open chat
1
Contact with us now
Chat with Anna
¡Hola! 👋🏻
Soy Anna, ¿en qué puedo ayudarte?

The user who fills in the information requested in this form declares to be entitled to do so and is solely responsible for the accuracy and completeness of the data and information entered, expressly exonerating MJN NEUROSERVEIS of any liability that may arise for this entity on the occasion of the information provided through this form.

Yes, I accept

L’usuari que complimenta la informació requerida al present formulari declara estar legitimat per això i es fa responsable exclusiu de la veracitat i integritat de les dades i informació que introdueix, exonerant expressament a MJN NEUROSERVEIS de qualsevol responsabilitat que es pugi generar per aquesta entitat amb ocasió de la informació facilitat a través del present formulari.

Si, accepto

El usuario que cumplimenta la información requerida en el presente formulario declara estar legitimado para ello y se hace responsable exclusivo de la veracidad e integridad de los datos e información que introduce, exonerando expresamente a MJN NEUROSERVEIS de cualquier responsabilidad que pudiera generarse para esta entidad con ocasión de la información facilitada a través del presente formulario.

Sí, acepto

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!


    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.
    CPSP20103CAT.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.

    ¡Inscríbete!

      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.
      CPSP20103CAT.